ANTINEOVASCULARISATION AGENTS
- aflibercept (YESAFILI, ENZEEVU, AFLIVU, PAVBLU, EYLEA HD, EYLEA, EYDENZELT)
- brolucizumab (BEOVU)
- faricimab (VABYSMO)
- ranibizumab (LUCENTIS, MELVIZO, RANOPTO)
- verteporfin (VISUDYNE)
Using Health Canada Drug Database
updated on 11Apr2026.